- Investing Ideas
- Canadian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Canadian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
18
Companies which are more than 50% undervalued based on analyst price target.
18 companies
Green Thumb Industries
Market Cap: CA$2.5b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$10.78
7D
3.0%
1Y
47.9%
Verano Holdings
Market Cap: CA$634.0m
Engages in the cannabis business in the United States.
VRNO
CA$8.70
7D
6.5%
1Y
163.6%
Eupraxia Pharmaceuticals
Market Cap: CA$608.2m
A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.
EPRX
CA$9.45
7D
3.6%
1Y
27.9%
Cresco Labs
Market Cap: CA$531.3m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.
CL
CA$1.16
7D
-0.9%
1Y
75.8%
Spectral Medical
Market Cap: CA$387.3m
Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.
EDT
CA$1.34
7D
-0.7%
1Y
65.4%
TerrAscend
Market Cap: CA$358.1m
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.
TSND
CA$0.90
7D
-5.8%
1Y
140.0%
High Tide
Market Cap: CA$283.8m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.23
7D
3.5%
1Y
1.3%
Satellos Bioscience
Market Cap: CA$222.1m
A clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia.
MSCL
CA$10.20
7D
6.0%
1Y
34.9%
Organigram Global
Market Cap: CA$203.4m
Engages in the production and sale of cannabis and cannabis-derived products in Canada.
OGI
CA$1.45
7D
6.6%
1Y
-24.1%
Cardiol Therapeutics
Market Cap: CA$171.8m
A clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
CRDL
CA$1.54
7D
2.0%
1Y
-24.9%
HLS Therapeutics
Market Cap: CA$137.9m
A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally.
HLS
CA$4.25
7D
-0.2%
1Y
-13.3%
Decibel Cannabis
Market Cap: CA$69.2m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.12
7D
-4.2%
1Y
64.3%
Vext Science
Market Cap: CA$55.7m
Through its subsidiaries, engages in integrated cannabis operations in the United States.
VEXT
CA$0.23
7D
-11.5%
1Y
31.4%
Sernova Biotherapeutics
Market Cap: CA$51.0m
Operates as a clinical-stage biotechnology company in Canada.
SVA
CA$0.13
7D
-7.1%
1Y
-13.3%
Optimi Health
Market Cap: CA$41.6m
Operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada.
OPTI
CA$7.00
7D
20.7%
1Y
45.8%
Medicenna Therapeutics
Market Cap: CA$36.5m
A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.
MDNA
CA$0.38
7D
-8.4%
1Y
-57.8%
Rubicon Organics
Market Cap: CA$31.8m
Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.
ROMJ
CA$0.45
7D
0%
1Y
-6.3%
Delivra Health Brands
Market Cap: CA$3.1m
Through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide.
DHB
CA$0.10
7D
0%
1Y
-52.4%